Evaluation of Copper, Zinc, Cu/Zn, and VEGF in Patients with AML in Iran
| Author | Zohreh Sanaat | en |
| Author | M Nouri | en |
| Author | B Hajipour | en |
| Author | R Dolatkhah | en |
| Author | I Asvadi | en |
| Author | J Vaez | en |
| Author | J Eivazi | en |
| Author | A Nikanfar | en |
| Author | A Esfahani | en |
| Author | SH Chavoshi | en |
| Author | H Biorani | en |
| Issued Date | 2011-12-31 | en |
| Abstract | Background: Copper and zinc are the elements with numerous physiological activities. Copper (Cu) has an important role in angiogenesis and acts by increasing Vascular Endothelial Growth Factor (VEGF). Serum levels of copper will be increased in cancer incidence, progression and recurrence. The aim of this study was to measure blood levels of copper, zinc, and the ratio of Cu /Zn, as well as VEGF levels before and after treatment of acute myeloid leukemia. | en |
| DOI | https://doi.org/ | en |
| URI | https://brieflands.com/journals/ijcm/articles/80749 | en |
| Keyword | Copper | en |
| Keyword | Zinc | en |
| Keyword | Vascular Endothelial Growth Factor A | en |
| Publisher | Brieflands | en |
| Title | Evaluation of Copper, Zinc, Cu/Zn, and VEGF in Patients with AML in Iran | en |
| Type | Brief Report | en |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- IJCM-80749.pdf
- Size:
- 178.78 KB
- Format:
- Adobe Portable Document Format
- Description:
- Article/s PDF